Title : Efficacy and Safety of Oral P2Y12 Inhibitors in Older Patients with Acute Coronary Syndrome: A Frequentist Network Meta-Analysis.

Pub. Date : 2021 Nov

PMID : 34664214






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ranking by p-score suggests prasugrel as the best P2Y12 inhibitor to reduce the risk of MACE while clopidogrel is a better alternative than ticagrelor in older patients with acute coronary syndrome to decrease the risk of major bleeding. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens